Abbott (NYSE:ABT) said today that its next-generation FreeStyle Libre system won CE Mark clearance in the European Union.
The glucose monitor, which eliminates the need for finger sticks, features optional alarms that users can customize, according to Abbott.
Get the full story at our sister site, Drug Delivery Business News.
The post Abbott’s next-gen FreeStyle Libre wins CE Mark appeared first on MassDevice.
from MassDevice https://ift.tt/2xOPKm8
Cap comentari:
Publica un comentari a l'entrada